David Peston

2.1k total citations
26 papers, 1.5k citations indexed

About

David Peston is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, David Peston has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in David Peston's work include HER2/EGFR in Cancer Research (6 papers), Breast Cancer Treatment Studies (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). David Peston is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Breast Cancer Treatment Studies (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). David Peston collaborates with scholars based in United Kingdom, United States and Belgium. David Peston's co-authors include Sami Shousha, Tonia L. Vincent, Louise E. Full, Celia McLean, Jeremy Saklatvala, David L. Moyes, Karin Lundberg, Peter C. Taylor, Robin Wait and A. J. Kinloch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Lancet Oncology.

In The Last Decade

David Peston

26 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Peston United Kingdom	15	724	546	337	283	259	26	1.5k
J Jacquemier France	18	859 1.2×	601 1.1×	197 0.6×	463 1.6×	238 0.9×	40	1.8k
Yutaka Kawakami Japan	22	915 1.3×	777 1.4×	376 1.1×	305 1.1×	90 0.3×	37	2.4k
Henrik Hjorth‐Hansen Norway	27	859 1.2×	774 1.4×	469 1.4×	196 0.7×	102 0.4×	74	2.8k
George Κ. Koukoulis Greece	26	570 0.8×	516 0.9×	229 0.7×	264 0.9×	131 0.5×	71	2.2k
Linda Kapusta Canada	16	1.1k 1.5×	902 1.7×	152 0.5×	409 1.4×	235 0.9×	23	2.1k
Thea M. Vroom Netherlands	19	421 0.6×	442 0.8×	157 0.5×	126 0.4×	175 0.7×	26	1.4k
L Andrac France	25	661 0.9×	659 1.2×	93 0.3×	370 1.3×	172 0.7×	75	1.5k
Cox Eb United States	8	685 0.9×	565 1.0×	668 2.0×	369 1.3×	294 1.1×	10	2.7k
Chris Morehouse United States	24	477 0.7×	580 1.1×	732 2.2×	151 0.5×	260 1.0×	42	2.2k
Antonio D’Antonio Italy	18	640 0.9×	385 0.7×	110 0.3×	235 0.8×	133 0.5×	96	1.3k

Countries citing papers authored by David Peston

Since Specialization

Citations

This map shows the geographic impact of David Peston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Peston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Peston more than expected).

Fields of papers citing papers by David Peston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Peston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Peston. The network helps show where David Peston may publish in the future.

Co-authorship network of co-authors of David Peston

This figure shows the co-authorship network connecting the top 25 collaborators of David Peston. A scholar is included among the top collaborators of David Peston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Peston. David Peston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stebbing, Justin, Rachel Payne, Jonathan Krell, et al.. (2011). Epidermal growth factor receptor status in early stage breast cancer is associated with cellular proliferation but not cross-talk. Journal of Clinical Pathology. 64(9). 829–831. 5 indexed citations

Ngo, Nye Thane, Emile Tan, Paris Tekkis, David Peston, & Patrizia Cohen. (2010). Differential expression of p53 and p504s in hyperplastic polyp, sessile serrated adenoma and traditional serrated adenoma. International Journal of Colorectal Disease. 25(10). 1193–1200. 4 indexed citations

Shousha, Sami, David Peston, B.K. Amo-Takyi, Matthew A. Morgan, & Bharat Jasani. (2009). Evaluation of automated silver‐enhanced in situ hybridization (SISH) for detection of HER2 gene amplification in breast carcinoma excision and core biopsy specimens. Histopathology. 54(2). 248–253. 38 indexed citations

Vincent, Tonia L., Celia McLean, Louise E. Full, David Peston, & Jeremy Saklatvala. (2007). FGF-2 is bound to perlecan in the pericellular matrix of articular cartilage, where it acts as a chondrocyte mechanotransducer. Osteoarthritis and Cartilage. 15(7). 752–763. 180 indexed citations

Jiang, Jie, Naveed Sarwar, David Peston, et al.. (2007). Phosphorylation of Estrogen Receptor-α at Ser167 Is Indicative of Longer Disease-Free and Overall Survival in Breast Cancer Patients. Clinical Cancer Research. 13(19). 5769–5776. 74 indexed citations

Roncaroli, Federico, et al.. (2007). OCTOBER 2006: A 37‐YEAR OLD MALE WITH HEADACHE. Brain Pathology. 17(2). 251–252. 2 indexed citations

Sarwar, Naveed, Jie Jiang, David Peston, et al.. (2006). Phosphorylation of ERα at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERα phosphorylation in breast cancer progression. Endocrine Related Cancer. 13(3). 851–861. 83 indexed citations

Polychronis, Andreas, H D Sinnett, Dimitri Hadjiminas, et al.. (2005). Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial. The Lancet Oncology. 6(6). 383–391. 160 indexed citations

Hegyi, László, David Peston, Maria Theodorou, et al.. (2005). Primary Glial Tumor of the Retina With Features of Myxopapillary Ependymoma. The American Journal of Surgical Pathology. 29(10). 1404–1410. 14 indexed citations

10.

Kinloch, A. J., Robin Wait, David Peston, et al.. (2005). Identification of citrullinated α-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Research & Therapy. 7(6). R1421–9. 285 indexed citations

11.

Powles, Tom, Mark Nelson, Ann Sandison, et al.. (2004). Head and neck cancer in patients with human immunodeficiency virus-1 infection: incidence, outcome and association with Epstein-Barr virus. The Journal of Laryngology & Otology. 118(3). 207–212. 16 indexed citations

12.

Sebire, Neil J., Helen C. Rees, David Peston, et al.. (2004). p57^KIP2 immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy. Histopathology. 45(2). 135–141. 12 indexed citations

13.

Farrar, Mark D., et al.. (2004). Immunocytochemical analysis of AE1/AE3, CK 14, Ki-67 and p53 expression in benign, premalignant and malignant oral tissue to establish putative markers for progression of oral carcinoma. British Journal of Biomedical Science. 61(3). 117–124. 14 indexed citations

14.

Ackerman, Zvi, David Peston, & Patrizia Cohen. (2003). Role of Helicobacter pylori Infection in Complications from Meckel's Diverticulum. Digestive Diseases and Sciences. 48(6). 1068–1072. 12 indexed citations

15.

Peston, David, et al.. (2001). CD9 immunohistochemical staining of breast carcinoma: unlikely to provide useful prognostic information for routine use^*. Histopathology. 39(6). 572–577. 12 indexed citations

16.

Walsh, Rebecca, David Peston, & Sami Shousha. (2001). Comparison of Immunoperoxidase Staining of 3 Different Types of CD5 Antibodies in a Spectrum of Breast Lesions. Archives of Pathology & Laboratory Medicine. 125(6). 781–784. 6 indexed citations

17.

Peston, David, et al.. (2001). Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study. Journal of Clinical Pathology. 54(12). 956–960. 109 indexed citations

18.

Tambiah, J., I J Franklin, Nigel J. Trendell‐Smith, David Peston, & Janet T. Powell. (2001). Provocation of experimental aortic inflammation and dilatation by inflammatory mediators and Chlamydia pneumoniae. British journal of surgery. 88(7). 935–940. 17 indexed citations

19.

Brown, Joel S., et al.. (1997). Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma.. Journal of Clinical Pathology. 50(1). 27–29. 67 indexed citations

20.

Fredersdorf, S, Jorge S. Burns, Graham Packham, et al.. (1997). High level expression of p27 ^kip1 and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27 ^kip1 and degree of malignancy in human breast and colorectal cancers. Proceedings of the National Academy of Sciences. 94(12). 6380–6385. 328 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact